OSTX
OS Therapies Incorporated
0.8722
-0.04 (-4.48%)
52w low 0.5800
2.25 high
17.5% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | -- | 4.84M | 6.88M | 11.99M | 10.17M | 8.58M | |
| R&D | -- | 2.50M | 3.76M | 8.80M | 7.35M | 6.07M | |
| SG&A | -- | 2.34M | 3.12M | 3.19M | 2.82M | 2.50M | |
| Operating Income | -- | -4.84M | -6.88M | -11.99M | -10.17M | -8.58M | |
| EBITDA | -- | -4.42M | -6.75M | -13.34M | -10.20M | -8.50M | |
| Pretax Income | -- | -4.54M | -6.88M | -13.46M | -10.40M | -8.63M | |
| Net Income | -- | -4.54M | -6.88M | -13.46M | -10.40M | -8.63M | |
| EPS Diluted | -0.18 | -0.19 | -0.21 | -- | -0.27 | -0.20 | |
| Diluted Shares | 21.25M | 25.11M | 31.96M | -- | 38.67M | 43.90M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--